The West Orange Township Council tabled an ordinance that would update the zoning provisions in town to allow the legal operation of medical marijuana dispensaries at its Jan. 7 meeting, wanting more information from attorney Mark Moon and more time to work with township officials on the ordinance.
A court has put review of medical marijuana business licenses on hold yet again after a rejected applicant seeking to open a business sued, saying the state Health Department wrongfully evaluated its application.
Progressive Treatment Solutions of New Jersey filed for a stay after the health department rejected its application to open a dispensary and cultivation center in Edison on Nov. 18. A two-judge appellate court panel granted an emergent motion for a stay Jan. 6.
"The Apothecarium" has set a spring opening for its newest location in Phillipsburg.
A marijuana growing operation in Morris County for global cannabinoid company TerrAscend, which owns The Apothecarium, was recently approved by the New Jersey Department of Health.
Cannabis company TerrAscend Corp. (CSE: TER) TRSSF 1.02% announced Thursday that TerrAscend NJ, LLC has obtained a permit from the New Jersey Department of Health to grow medical cannabis.
Its cultivation permit was the second out of the six applicants selected by the state agency in December, the company said. Growing operations will start right away at its facility in Boonton Township, TerrAscend said.
Some licenses were denied because of technical errors. Bauchner challenged the decision in court, arguing the applications should be issued based on merit.
In December, the court granted a stay in the 2019 application process for new medical marijuana businesses. That led to the appeals process and the delay in awarding licenses.
The state health department, however, believed it did not need to stop scoring applications that had passed an initial review. The court told the department it had misinterpreted its order.
A medical marijuana facility in Phillipsburg is closer to reality.
The New Jersey Department of Health on Thursday announced it has approved a Morris County marijuana-growing operation for TerrAscend, which will provide marijuana for the company’s eventual treatment center in Warren County.
TerrAscend owns The Apothecarium, a posh dispensary chain with storefronts in San Francisco and Las Vegas, and anticipates the Phillipsburg location will open in 2020’s second quarter. It will be the first Apothecarium on the East Coast.
"We are pleased to receive our cultivation permit in New Jersey after a rigorous inspection of our facility and operating procedures by the NJ DOH," said Jason Ackerman , Executive Chairman of TerrAscend. "Achieving this important regulatory milestone indicates that the TerrAscend model of compliance, quality and safety resonates with state regulatory agencies. Bringing safe and effective products to patients is our priority, and we look forward to introducing the TerrAscend house of brands to the state's medical-use patients."
TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) (“TerrAscend” or “the Company”), the first and only global cannabis company licensed for sales in Canada, the U.S., and the EU, today announced that TerrAscend NJ, LLC (“TerrAscend NJ”) has been issued a permit to cultivate medical marijuana by the New Jersey Department of Health (“NJ DOH”). TerrAscend NJ is the second entity to receive its cultivation permit among the six applicants chosen by the NJ DOH in December 2018. Cultivation operations will commence immediately at its facility in Boonton Township, located in northern New Jersey.
More than a year after the New Jersey Department of Health granted initial approval to a Chicago-based company’s proposal to open a medical marijuana facility in Mercer County, the firm is expected to seek approvals at the municipal level.
The planned expansion of New Jersey’s medical marijuana sector could be delayed after the state Department of Health hit a legal snag.
Earlier this year the Garden State announced it would issue 108 extra licenses to cannabis businesses, comprising 54 dispensary licenses, 30 processing permits, and 24 cultivation licenses. It received 190 applications for those 24 cultivation licenses and it disqualified 51 of them for reasons ranging from corrupted files to lack of local approval, lack of site control and the non-payment of fees.